Evaluation of the effect of nicotinic acid (niacin) on elevated lipoprotein(a) levels (NICOLa Study).
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2015
At a glance
- Drugs Niacin (Primary)
- Indications Hyperlipoproteinaemia
- Focus Therapeutic Use
- Acronyms NICOLa
- 05 Aug 2009 Planned end date changed from 1 Jan 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 05 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2008 New trial record.